Live Quote · NASDAQENLVHealthcare· Biotechnology

Enlivex Therapeutics Ltd.

$1.05▼ 10.26%($-0.12)
MKT CAP $17.67MNEXT EARNINGS Nov 27, 2026
50%
Bullish
TickerSpark Score
61/100
▌ Mixed
100
Valuation
60
Profitability
60
Growth
56
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ENLV research report →

Analyst Price Target
$15.00+1328.6% vs. today

Range $15 – $15

Analyst RatingBuy
3 Buy1 Hold0 Sell

Price Chart

-99.52% · this period
$290.40$145.72$1.05Nov 20May 26Nov 20
52-Week Range0% of range
Low
$1.00
Current
$1.05
High
$434.40